Department of Health and Human Services June 18, 2020 – Federal Register Recent Federal Regulation Documents

Injury Prevention Program; Tribal Injury Prevention Cooperative Agreement Program (TIPCAP)
Document Number: 2020-13180
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, Indian Health Service
Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
Document Number: 2020-13139
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institutes of Health, National Cancer Institute (NCI) will publish periodic summaries of propose projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
Prospective Grant of an Exclusive Patent License: Development and Commercialization of Cell Therapies for Cancer
Document Number: 2020-13137
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, National Institutes of Health
The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this Notice to Ziopharm Oncology, Inc. (``Ziopharm''), headquartered in Boston, MA.
Proposed Collection; 60-Day Comment Request: The National Institute of Mental Health Data Archive (NDA), NIMH
Document Number: 2020-13136
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, National Institutes of Health
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute of Mental Health (NIMH), National Institutes of Health (NIH), will publish periodic summaries of propose projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2020-13098
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings
Document Number: 2020-13097
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Document Number: 2020-13096
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Nursing Research; Notice of Closed Meeting
Document Number: 2020-13095
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
Document Number: 2020-13094
Type: Notice
Date: 2020-06-18
Agency: Department of Health and Human Services, National Institutes of Health
Agency Information Collection Activities; Proposed Collection; Comment Request; Obtaining Information To Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities
Document Number: 2020-13086
Type: Notice
Date: 2020-06-18
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on information collection associated with FDA research in obtaining information from pharmacists and other management at outsourcing facilities as well as at related compounding businesses to support a comprehensive analysis of the outsourcing facility sector that will inform ongoing FDA work in this area.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.